Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes. Song A, Altabbakh O, Sallman DA, Padron E, et al. Eur J Haematol 2021;107:609-616.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Song A, Altabbakh O, Sallman DA, Padron E, et al. Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes. Eur J Haematol 2021;107:609-616.
PMID: 34407254